Effects of an Activity Control System in Patients With Diabetes: a Randomized Controlled Trial
Diabetes Mellitus, Type 2
About this trial
This is an interventional health services research trial for Diabetes Mellitus, Type 2 focused on measuring artificial intelligence, diabetes mellitus, self-care, telemedicine
Eligibility Criteria
Inclusion Criteria:
- ≥ 18 years, with the ability to give informed consent
- Patient who has autonomy to carry out activities of daily living (Barthel = 100)
- patient diagnosed with Diabetes Mellitus
- patient in pharmacological treatment
- To live alone or with a person who cannot move on their own
- they do not plan to change their address in the 6 months after inclusion in the study
Exclusion Criteria:
• DM2 patients whose most recent HbA1c value is ≤7%
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Beprevent
patients only evaluated
10 will become part of the intervention group. Each of the participants in the intervention group is selected. At first, they are given a series of questionnaires, later (1 day later) we stay at their home to install the Beprevent device, which will remain in their home for a period of two weeks, to finish and once the device of your home, we will proceed to pass the same questionnaires as at the beginning of the test, in order to compare results.
10 will be included in the control group. During the period of the study, we will pass the same questionnaires in the participants assigned to the control group, also leaving a time interval of two weeks, and no device will be installed, nor will any monitoring be carried out in their homes.